WHO adds two more Ebola vaccines to clinical trial
The World Health Organization (WHO) will add two more Ebola vaccines to the ongoing Tumaini clinical trial. The Phase II/III…
News
Gilead seeks wider use for Livdelzi on Phase III liver disease success
Amgen’s Repatha reduces heart attack risk in real-world study
Mondego Bio begins Phase Ia trial of oral MB‑388
Gan & Lee’s obesity drug maintains weight loss in Phase III trial
“Urgent action” needed as UK trial recruitment falls again
Intellia concludes Phase III ATTRv-PN study enrolment
Tango and Erasca’s Phase I/II trial of ERAS-0015 combo opens for enrolment
